Charles River Laboratories International, Inc.

(NYSE:CRL)

22.24

+0.99 (4.66%)

Dec 02 - Close

Open
21.55
High
22.31
Low
21.00
Vol.
1.17M
Mkt Cap
1.44B
52Wk High
69.19
52Wk Low
19.92
Avg. Vol.
1.38M
P/E (Trailing)
8.89
Beta
0.54
Short %
2.50%
Div. Yield
—

After-Hours 23.91 +1.67 (7.51%) Tue, 2 Dec 2008 7:40 PM

Company Profile

Charles River Laboratories International, Inc.

251 Ballardvale Street

Wilmington, MA 01887

United States - Map

Phone: (781) 222-6000

Fax: (978) 658-7132

Website: www.criver.com

CEO: James C. Foster

Employees: 8,500

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Critical research tools and support services

The Company is a global provider of solutions that accelerate the drug discovery and development process including research models and associated services, and outsourced preclinical services.

Recent news for CRL

Recent opinions on CRL

No recent Opinions for CRL

Top members owning CRL

  • Top 47%

    Iluvatar

    Iluvatar

    -31.59%3m:

    -37.27%YTD:

  • Top 27%

    dkchun

    dkchun

    -15.71%3m:

    -15.71%YTD:

  • New

    arielmbg

    arielmbg

    -1.38%3m:

    -1.38%YTD:

Members owning CRL also own

FAX (33.33%), BCS (33.33%), BGC (33.33%), NG (33.33%), CHK (33.33%)

Member sentiment: Sell